Published in Women's Health Weekly, March 30th, 2006
According to a study from Finland, "VEGF promotes placental vascularization, which is inadequate in preeclampsia and intrauterine growth retardation (IUGR). The sVEGFR-1, also known as soluble fms-like tyrosine kinase-1, is produced in the placenta and reduces VEGF activity."
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly